MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
Background. Monitoring of serum digoxin concentration (SDC) is one of the approaches for controlling the safety of the long-term digoxin treatment, however, the benefits from SDC monitoring in paroxysmal arrhythmias have not been studied.Aim. To evaluate the potential benefits of digoxin laboratory...
Saved in:
Main Authors: | S. F. Zadvorev (Author), A. A. Yakovlev (Author), A. S. Pushkin (Author), S. A. Rukavishnikova (Author), A. E. Filippov (Author), A. G. Obrezan (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OPTIMIZATION OF THE HEART RATE CONTROL IN ATRIAL FIBRILLATION BY MONITORING OF THE DIGOXIN CONCENTRATION IN ELDERLY PATIENTS
by: S. F. Zadvorev, et al.
Published: (2018) -
Digoxin Therapy of Fetal Superior Ventricular Tachycardia: Are Digoxin Serum Levels Reliable?
by: Antonio F. Saad, et al.
Published: (2016) -
A Comparison of Verapamil and Digoxin for Heart Rate Control in Atrial Fibrillation
by: Mohammad Afzali Moghadam, et al.
Published: (2012) -
Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study
by: Kuan-Cheng Lai, et al.
Published: (2018) -
Drug therapy monitoring (TDM) of Digoxin: safety and efficacy review
by: Rony Abdi Syahputra, et al.
Published: (2022)